Cleveland Biolabs, Inc. (CBLI) down another 5%, Here’s why
Cleveland Biolabs, Inc. (CBLI) is down another 5% in pre-market trading on Thursday after losing 5.9% in the regular trading session on Wednesday. The declines came after the company announced publication of the next Generation Deimmunized TLR5 Agonist, GP532. About Cleveland Biolabs Inc. Cleveland Biolabs Inc. was founded in 2003, and has its headquarters in […]